All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF905 | Anti-Human ULBP2 (XW-905) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-905 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF906 | Anti-Human ULBP2 (XW-906) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-906 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF907 | Anti-Human ULBP2 (XW-907) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-907 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF908 | Anti-Mouse ULBP2 (XW-908) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-908 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1825 | Anti-Human ULBP2 (XW-905) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-905 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1826 | Anti-Human ULBP2 (XW-906) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-906 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1827 | Anti-Human ULBP2 (XW-907) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-907 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1828 | Anti-Mouse ULBP2 (XW-908) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-908 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2745 | Anti-Human ULBP2 (XW-905) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-905 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2746 | Anti-Human ULBP2 (XW-906) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-906 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2747 | Anti-Human ULBP2 (XW-907) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-907 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2748 | Anti-Mouse ULBP2 (XW-908) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-908 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0123-ZP284 | Anti-ULBP2 (NN0604-8G44) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | NN0604-8G44 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP285 | Anti-ULBP2 (CBL196) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | CBL196 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP286 | Anti-ULBP2 (MM0593-7F33) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | MM0593-7F33 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP529 | Anti-ULBP2 (CB-P20) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | CB-P20 | Rat | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP284 | Anti-ULBP2 (NN0604-8G44 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | NN0604-8G44 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP285 | Anti-ULBP2 (CBL196 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | CBL196 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP286 | Anti-ULBP2 (MM0593-7F33 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | MM0593-7F33 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP529 | Anti-ULBP2 (CB-P20 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | CB-P20 | Rat | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION